
Cardiovascular diseases remain the leading cause of morbidity and mortality worldwide. In recent years, significant progress has been made in understanding the molecular pathways that link metabolic disorders, systemic inflammation, and cardiovascular dysfunction.
This webinar brings together experts in molecular cardiology and translational medicine to discuss emerging mechanisms underlying cardiovascular inflammation, metabolic dysregulation, and their clinical implications. The presentations will highlight novel biomarkers, molecular pathways, and potential therapeutic targets that may improve prevention and treatment strategies for cardiovascular disease.
We hope that this event will stimulate discussion and foster collaborations among researchers and clinicians who are interested in the molecular basis of cardiovascular pathology.
Date: 20 May 2026
Time: 9:00 am CEST | 3:00 pm CST (Asia) | 5:00 pm AEST
Webinar ID: 868 7188 7021
Webinar Secretariat: journal.webinar@mdpi.com



| Speaker | Presentation | Time (CEST) | Time (AEST) |
|---|---|---|---|
| IJMS Journal Introduction | 09:00–09:10 | 17:00–17:10 | |
| Prof. Dr. Celestino Sardu | Chair Opening | 09:10–09:20 | 17:10–17:20 |
| Prof. Dr. Celestino Sardu | Metabolic Dysregulation and Cardiovascular Inflammation: Emerging Mechanisms and Therapeutic Targets | 09:20–09:40 | 17:20–17:40 |
| Dr. Carlo Fumagalli | Age and Ageing in Cardiovascular Disease: From Cardiac Amyloidosis to Valvular Heart Disease and Heart Failure | 09:40–10:00 | 17:40–18:00 |
| Dr. Susan Campbell | A Shifting Focus in Cardiovascular Disease: Targeting Residual Inflammatory Risk | 10:00–10:20 | 18:00–18:20 |
| Q&A | 10:20–10:35 | 18:20–18:35 | |
| Prof. Dr. Celestino Sardu | Closing Remarks | 10:35–10:40 | 18:35–18:40 |
"Molecular Mechanisms, Biomarkers, and Therapeutic Targets in Heart Failure"
Special Issue Editor: Prof. Dr. Celestino Sardu
Deadline for manuscript submissions: 31 August 2026